Níveis séricos pré-operatórios e imunoexpressão tecidual do marcador tumoral CA 242 no carcinoma colorretal: relação com os aspectos anatomopatológicos da neoplasia
Conteúdo do artigo principal
Resumo
Detalhes do artigo
Referências
Carpelan-Holmström M, Haglund C, Kuusela P, Järvinen H, Roberts PJ. Preoperative serum levels of CEA and CA 242 in colorectal cancer. Br J Cancer 1995;71(4):868-72. http://dx.doi.org/10.1038/bjc.1995.167
Kuusela P, Haglund C, Roberts PJ. Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer 1991;63(4):636-40. http://dx.doi.org/10.1038/bjc.1991.146
Haglund C, Lundin J, Kuusela P, Roberts PJ. CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. J Cancer 1994;70(3):487-92. http://dx.doi.org/10.1038/bjc.1994.332
Valean S, Mircea PA, Oprea L, Frentiu D, Popescu G, Nagy G, et al. Trends of mortality rates from gastric cancer and colorectal cancer in Romania, 1955-2003. J Gastrointestin Liver Dis 2006;15(2):111-5.
Carr-Locke DL. Serum and pancreativ juice carcinoembryonic antigen in pancreatic and billiary disease. Gut 1980;21(8):656. http://dx.doi.org/10.1136/gut.21.8.656
Haglund C, Roberts PJ, Kuusela P, Schneinin TM, Mäkelä O, Jalanko H. Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer 1986;53(2):197.
http://dx.doi.org/10.1038/bjc.1986.35
Haglund C, Kuusela P, Jalanko H, Roberts PJ. Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9. Int J Cancer 1987;39(4):477. http://dx.doi.org/10.1002/ijc.2910390412
Nilsson O, Johansson C, Glimelius B, Persson B, Norgaard-Pedersen B, Andren-Sandberg A, et al. Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. Br J Cancer 1992;65(2):215-21. http://dx.doi.org/10.1038/bjc.1992.44
Carpelan-Holmström MA, Haglund CH, Roberts PJ. Differences in serum tumor markers between colon and rectal cancer. Comparison of CA 242 and carcinoembryonic antigen. Dis Colon Rectum 1996;39(7):799-805. http://dx.doi.org/10.1007/BF02054447
Carpelan-Holmström M, Haglund C, Lundin J, Alfthan H, Stenman U-H, Roberts PJ. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer. Br J Cancer 1996;74(6): 925-9. http://dx.doi.org/10.1038/bjc.1996.458
Carpelan-Holmström M, Haglund C, Lundin J, Järvinen H, Roberts P. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer. Eur J Cancer 1996;32A(2):1156-61. http://dx.doi.org/10.1016/0959-8049(96)00030-5
Carpelan-Holmström M, Louhimo J, Stenman UH, Alfthan H, Järvinen H, Haglund C. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer. Tumour Biol 2004;25(5-6):228-34. http://dx.doi.org/10.1159/000081385
Roberts PJ. Tumour markers in colorectal cancer. Scand J Gastroenterol 1988;23(S149):50-8 http://dx.doi.org/10.3109/00365528809096956
Roberts PJ, Kuusela P, Carpelan-Holmström M, Haglund C. Value of different tumour markers in colorectal cancer. In: Klapdor RW, editor. Tumour associated antigens, oncogenes, receptors, cytokines in tumour diagnosis and therapy at the beginning of the nineties. Munich: Zuckschwerdt; 1992. p. 30-32.
Carpelan-Holmström MA, Haglund CH, Järvinen HJ, Roberts PJ. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer. Anticancer Res. 1996;16(2):981-6.
Kuusela P, Haglund C, Roberts PJ. Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer 1991;63(4):636-40. http://dx.doi.org/10.1038/bjc.1991.146
Matos LL, Stabenow E, Tavares MR, Ferraz AR, Capelozzi VL, Pinhal MA. Immunohistochemistry quantification by digital computer-assisted method compared to semiquantitative analysis. Clinics 2006;61(5):417-24. http://dx.doi.org/10.1590/S1807-59322006000500008
Carpelan-Holmström M, Louhimo J, Stenman UH, Alfthan H, Järvinen H, Haglund C. Estimating the probability of cancer with several tumor markers in patients with colorectal disease. Oncology 2004;66(4):296-302. http://dx.doi.org/10.1159/000078330
Levy M, Visokai V, Lipska L, Topolcan O. Tumor markers in staging and prognosis of colorectal carcinoma. Neoplasma 2008;55(2):138-42.
Shahi SK, Ranga S, Bhullar C. CA 242--a step ahead. Indian J Pathol Microbiol 2002;45(2):145-6.
Kim SB, Fernandes LC, Saad SS, Matos D. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients. Int J Biol Markers 2003;18(3):182-7.
Forslund A, Engarås B, Lönnroth C, Lundholm K. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma. Int J Oncol 2002;20(5):1013-8.
Martin EW, Kibbey WE, DiVecchia L, Anderson G, Catalano P, Minton JP. Carcinoembryonic antigen: clinical and historical aspects. Cancer 1976;37(1):62-81. http://dx.doi.org/10.1002/1097-0142(197601)37:1<62::AID-CNCR2820370110>3.0.CO;2-#
Livingstone AS, Hampson LG, Shuster J, Gold P, Hinchey EJ. Carcinoembryonic antigen in the diagnosis and management of colorectal carcinoma. Current status. Arch Surg 1974;109(2):259-64. http://dx.doi.org/10.1001/archsurg.1974.01360020119023
Bivins BA, Meeker WR, Griffen WO. Carcinoembryonic antigen (CEA) levels and tumor histology in colon cancer. Surg J Res 1975;18(3): 257-61. http://dx.doi.org/10.1016/0022-4804(75)90149-3
Joint Cancer National Institute of Canada/American Cancer Society Investigation. A collaborative study of a test for carcinoembryonic antigen (CEA) in the sera of patients with carcinoma of the colon and rectum. Can Med Assoc J 1972;107(1):25-33.
Bukeirat FA, Ostrinsky Y, McFadden D. Use of GI tumor markers in clinical practice: a practical interpretation. W V Med J 2008;104(4):17-21.
Shukla VK, Gurubachan, Sharma D, Dixit VK, Usha. Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder. Trop Gastroenterol. 2006;27(4):160-5.
Engarås B. Individual cutoff levels of carcinoembryonic antigen and CA 242 indicate recurrence of colorectal cancer with high sensitivity. Dis Colon Rectum 2003;46(3):313-21. http://dx.doi.org/10.1007/s10350-004-6548-7